KELLERMAN DONALD J 4
4 · Zosano Pharma Corp · Filed Apr 1, 2021
Insider Transaction Report
Form 4
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Transactions
- Award
Common Stock
2021-03-30+32,500→ 52,046 total - Award
Stock Option (Right to Buy)
2021-03-30+65,000→ 65,000 totalExercise: $1.20Exp: 2031-03-29→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units which vest in substantially equal annual installments on each of the first four anniversaries of March 30, 2021 subject to the Reporting Person's continued service to the Issuer on each applicable vesting date.
- [F2]The shares underlying the stock option vest in equal monthly installments over a four-year period, beginning on March 30, 2021, so that all shares shall have vested on March 30, 2025.